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Abstract
We performed a multipoint linkage analysis for rheumatoid arthritis (RA) using high-density single-
nucleotide polymorphism (SNP) data for chromosome 6 and chromosome 21 using Genetic
Analysis Workshop 15 (GAW15) data. These regions were previously shown to have high LOD
scores, not accounting for linkage disequilibrium (LD). We propose three novel methods to
control for LD in a linkage analysis: allow for LD between markers using graphical modeling,
eliminate high-LD markers by principal-component analysis (PCA) using haplotype data, and
eliminate high-LD markers by PCA using genotype data. All three novel methods were compared
to the previously published SNPLINK high-LD elimination method. Although all four methods
verified the previous results, differences in linkage peak height and position were observed across
methods. Additional work is required to further understand the effects of LD on linkage results
and explore LD control methodology.
Background
The recent availability of rapid, accurate, and relatively
low-cost genome-wide, high-density single-nucleotide
polymorphism (SNP) panels is changing the study of
many complex diseases. Linkage analysis to track inherit-
ance of chromosomal regions in pedigrees no longer must
rely on highly informative but sparsely spaced conven-
tional microsatellite markers. Rather, SNPs, which are far
more abundant than microsatellite markers, have the
capacity to yield a higher information content, and hence
an improved potential for localizing disease genes [1].
Classical linkage analysis assumes linkage equilibrium
between markers. Applying classical linkage packages to
genome-wide SNP panels may generate biased results, if
parental genotypes are missing, as SNP panels will include
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markers that are in linkage disequilibrium (LD). LD
between markers may inappropriately weight shared hap-
lotypes in the likelihood calculations, which can lead to
inflated LOD scores, resulting in false-positive evidence of
linkage [2]. To overcome the potential bias in a linkage
analysis by using SNP data, ideally LD must either be
incorporated into the analysis or markers in high LD must
be eliminated. The commonly used, freely available
SNPLINK [3] program eliminates high-LD SNPs using a
simple algorithm between contiguous pairs of SNPs.
However, we have previously shown that a non-contigu-
ous LD structure is more likely to model the complex pat-
tern of recombination and mutation that have been
observed to exist in candidate genes [4,5].
Here we propose three novel methods to control for LD
between markers in a linkage analysis that do not require
a contiguous LD structure: one method that allows for LD
between markers using graphical modeling and two meth-
ods that eliminate markers in high LD using principal
components. Our three novel methods were compared to
the previously published analysis generated by the
SNPLINK [3] program. We used genome-wide scan data
made available for the Genetic Analysis Workshop
(GAW15), Problem 2. The North American Rheumatoid
Arthritis Consortium (NARAC) provided 5744 SNPs from
a genome-wide scan of 757 families, approximately 90%
of which were Caucasian. The NARAC Caucasian families
were previously analyzed by Amos et al. [6], who found
their two highest linkage results on chromosome 6 (LOD
= 18.53) and chromosome 21 (LOD = 11.59), not
accounting for LD. However, when markers in high LD
were eliminated using SNPLINK [3], Amos et al. [6] found
that the chromosome 6 peak remained (LOD = 16.14) but
the chromosome 21 peak disappeared (LOD = 1.11). By
reanalyzing the chromosome 6 and 21 peaks with three
novel LD control methods, we verify the previous results
and suggest alternative methods for controlling for high
LD without requiring contiguous LD structure.
Methods
Details regarding NARAC subject enrollment, phenotype
designation, and genotype information are published
elsewhere [6]. Using the total 404 SNPs available for chro-
mosome 6 and the 104 SNPs available from chromosome
21, we checked for genotype errors using the software
CheckErrors [7], which uses graphical modeling to calcu-
late the posterior probability of genotype errors in pedi-
grees. For chromosome 6 we eliminated 16 SNPs and for
chromosome 21 we eliminated 1 SNP because of errors.
We performed a linkage analysis on each of these cleaned
files using the multipoint Markov-chain Monte Carlo
(MCMC) linkage method MCLINK [8], which computes
the robust multipoint TLOD [9] statistic. For each chro-
mosome, we identified peak regions (TLOD ≥ 2.0), not
accounting for LD. To ensure that the peak could be
resolved in other analyses, we included ~20 SNPs on
either side of the peak and called these data our "Com-
plete" SNP sets. These linkage results are likely to be
biased because of underlying LD as 63.7% of the parents
in the data set were not genotyped.
The four methods (i.e., the three novel methods and
SNPLINK) were each applied to the "Complete" SNP data
files. For the graphical modeling of LD combined with
linkage analysis method, we used the new McLink soft-
ware http://www-genepi.med.utah.edu/~alun/software/,
which we will refer to as McLink-LD in this manuscript.
For the three LD elimination methods, we used both the
original MCLINK [8] and Merlin [10] software packages to
perform the linkage analyses. Allele frequencies were esti-
mated from observation of all genotyped individuals at
each locus, rather than only the founders. Genotype data
was available for only ~15% of the pedigree founders, and
because the total number of individuals with genotype
data was large (n = 1991 individuals) the estimated allele
frequencies from all genotyped individuals provides rea-
sonable estimates of the founder allele frequencies, even
without adjustment for familial relationships. The origi-
nal pedigree structure for all 757 pedigrees was used for all
analyses, except for the Merlin analyses, in which 56 large
pedigrees were removed because of memory limitations.
For the genetic map, we assumed that 1 Mb was equiva-
lent to 1 cM. Although this is a simplistic assumption,
when inter-marker distances are relatively short and when
a dense marker map is used, the assumption has been
shown to produce nearly identical linkage results as a
more detailed genetic map [11]. We performed a paramet-
ric analysis using a dominant model, assuming a minor
allele frequency of 0.01 and a penetrance of 0.008, 0.5,
and 0.5 for carriers of none, one, and two disease alleles,
respectively. Our parametric model results in an overall
prevalence rate of 7.5 cases per 1000 individuals, which is
consistent with published prevalence rates for rheumatoid
arthritis [12].
McLink-LD
Thomas and Camp [13] and Thomas [14] introduced
graphical modeling as an approach to represent allelic
association in a tractable way. A graphical model consists
of two elements: a Markov graph with vertices represent-
ing variables, which are connected in such a way that
given the states of its neighbors, the state of a variable is
conditionally independent of any other variable and the
parameters that specify the conditional dependences. In
the case of discrete data, these are given by multinomial
distributions on the states of the variables in the maximal
cliques of the graph. Thomas [14] developed a two-stage
scheme to apply this to data from a random sample of
diploids genotyped at multiple loci. In the first stage, anBMC Proceedings 2007, 1(Suppl 1):S160 http://www.biomedcentral.com/1753-6561/1/S1/S160
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initial graphical model is assumed, and given the
observed genotypes, an imputation of the haplotypes is
made. In the second stage, given the imputed haplotypes
a new graphical model is estimated. These stages are iter-
ated in a simulated annealing search for an optimal LD
model, and implemented in a program called HapGraph
http://www-genepi.med.utah.edu/~alun/software/.
Through application of graphical modeling to the haplo-
types of founders in a pedigree, we are able to obtain valid
linkage statistics for dense SNP loci without having to dis-
card any data. The new McLink-LD software, made availa-
ble by Alun Thomas, incorporates the LD model obtained
from graphical modeling and computes LOD score statis-
tics using MCMC methods similar to those described by
Thomas et al. [8] The program also models genotype
errors using the approach of Thomas and Camp [15], so
that checking for apparent Mendelian segregation is
unnecessary. Recombination fractions can be estimated
on the interval (0, 1) to take advantage of any potential
evidence for linkage and to identify possible model mis-
specification. Full details of the method, including use of
the program, are given by Thomas [16].
Although McLink-LD can estimate an LD model using a
large subset of unrelated individuals and it can also model
genotype errors, for consistency with our other LD elimi-
nation methods, LD assessment was performed on 100
unrelated, random individuals with genotype data
selected from the 757 rheumatoid arthritis families. LD
modeling using 100 individuals has been shown previ-
ously to be a sufficient sample size to capture the underly-
ing genetic variation [17]. All SNPs in the "Complete"
SNP sets were included in the analyses. Genotype errors
were previously eliminated from these data files. For con-
sistency with the other LD methods, the results displayed
are over the recombination fraction interval (0, 0.5).
PCA-haplotype method
Principal-component analysis (PCA) has been used for
selection of tagging-SNPs for candidate gene studies [4,5].
Advantages of PCA include that the methodology can cap-
ture the underlying genetic variation without redundancy,
genetic markers are not required to be contiguous, and
statistical packages (e.g., SAS, SPSS, STATA) are readily
available to perform analyses. Here we apply PCA meth-
odology to larger genomic regions of interest using both
haplotype data and genotype data. Applying the method
to haplotype data, we used the same 100 unrelated, ran-
dom individuals as described above as a subset of the total
arthritis resource to characterize the LD structure of the
regions. We performed pair-wise D' analysis for the 100
independent individuals and all pairs of SNPs in the
"Complete" SNP data sets using an in-house modified
version of the EMLD [18] software that increases the
number of markers that can be studied at one time. All
markers with a D' value ≥ 0.7 and within 2 million base
pairs of each other were considered for potential removal
due to high LD. These high-LD markers were phased using
the software SNPHAP [19], and the resulting haplotypes
were entered into PCA. Eigenvalue thresholds were set to
capture at least 90% of the genetic variation of extracted
factors. For each of the resulting LD groups, the SNP with
the highest factor loading (required to be ≥|0.4|) was
retained while all other SNPs were eliminated as provid-
ing redundant information. Linkage analysis was then
performed on the "Complete" SNP set containing all 757
families but modified to only include SNPs with D' < 0.7
and SNPs selected from the PCA analysis.
PCA-genotype method
For the PCA-Genotype method, we also used the same
100 unrelated, random individuals described above to
characterize LD. For each SNP we recoded all of the geno-
type data from the "Complete" SNP data sets as -1, 0, 1
[20]; corresponding to homozygous wild type (1, 1), het-
erozygous [(1, 2) or (2, 1)], or homozygous rare genotype
(2, 2), respectively. All of the recoded genotype data were
then entered into the two-step PCA analysis method pro-
posed by Horne and Camp [17]. The first PCA step was
performed as described above for the PCA-Haplotype
method. The second PCA step was used to select, among
multiple markers in an LD group with a factor loading
≥|0.4|, the marker(s) that best capture(s) the underlying
genetic variation. Because more markers are typically
included in each LD group in the PCA-Genotype method
compared to the PCA-Haplotype method, the two-step
rather than the single-step PCA methodology was utilized
here. As with the PCA-Haplotype method, we again mod-
ified the "Complete" SNP sets for all 757 families to only
include markers that were retained from the PCA analysis.
SNPLINK
SNPLINK [3] is a freely available Perl script that removes
markers in high LD by computing either D' or r2 between
consecutive marker pairs for all individuals in a data set,
ignoring relationships. Only one marker from each high-
LD pair of SNPs, based on a high-LD threshold defined by
the user, is retained. We defined high LD to be D' ≥ 0.7,
consistent with our PCA-Haplotype method. We success-
fully analyzed the chromosome 6 "Complete" SNP data
using SNPLINK, but found that SNPLINK halted unex-
pectedly when running the chromosome 21 data. There-
fore, using the SNPLINK protocol, we manually identified
which SNPs to eliminate because of high LD in both chro-
mosomes 6 and 21. Our results for chromosome 6 com-
pared well to the SNPLINK output. Four markers differed
between the two marker lists; we selected from among two
equal markers the opposite marker as that selected by
SNPLINK. Hence, we feel confident that our analysis ofBMC Proceedings 2007, 1(Suppl 1):S160 http://www.biomedcentral.com/1753-6561/1/S1/S160
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the chromosome 21 data set would be similar to the out-
put of SNPLINK had we been able to obtain it.
Results and Discussion
Descriptions of the peak region including the number of
markers studied and the median and interquartile dis-
tance between markers for the chromosome 6 and 21
regions are displayed in Table 1. The PCA-Genotype
method resulted in the fewest number of markers studied.
The PCA-Haplotype and SNPLINK methods resulted in a
comparable number of markers being studied. The
McLink-LD method, as described above, used the "Com-
plete" SNP data sets.
Graphical illustrations of the linkage results are provided
for McLink-LD and the LD elimination methods analyzed
in MCLINK in Figures 1 and 2. Because the Merlin peak
profiles were similar to the MCLINK output, we do not
provide a graphical illustration of those results. The max-
imum TLOD scores from MCLINK and McLink-LD and
the HLOD scores from Merlin are displayed in Table 2.
The linkage results after controlling for LD all consistently
verified the conclusions of Amos et al. [6], that is that the
chromosome 6 peak is a true-positive result and the chro-
mosome 21 peak is a false-positive result. For chromo-
some 21, all LD control methods behaved similarly with
peak values of ~1.0. However, larger peak differences
across methods were observed for chromosome 6 (range:
9.07 to 16.07). Peak position also varied on chromo-
somes 6 and 21. For chromosome 6, all methods that
removed high-LD SNPs peaked at 28.96 cM, whereas
McLink-LD peaked at 38.61 cM. We note that the HLA-
DRB1 gene, the best characterized single genetic risk factor
contributing to rheumatoid arthritis, maps between two
SNPs included in our data sets at 28.96 cM and 33.1 cM,
which is the peak location obtained from analysis of the
Complete data set and all LD elimination methods.
Although here we reported TLOD results as this is cur-
rently the only output of McLink-LD, rheumatoid arthritis
is a complex disease, and heterogeneity LOD (HLOD)
scores may more accurately reflect the true position of a
peak. However, it should be noted that the HLOD scores
from Merlin were reported at identical (or nearly identi-
cal) peak position values for the three LD-elimination
methods using MCLINK at both the chromosome 6 and
21 regions.
While a method that incorporates the underlying LD
structure should more accurately reflect the true linkage
peak height and position for a chromosomal region, it
may be too early to consider McLink-LD the 'gold stand-
ard'. MCMC methods can be problematic due to compu-
tational requirements and poor mixing properties and it
may not be suitable for use in all cases. We note that an
additional feature of the new McLink-LD program is max-
imization of LOD scores across recombination fractions
on the (0, 1) interval. The (0, 1) interval may better be
able to incorporate model errors and improve mixing
properties of the graphical LD model. Maximizing over
the (0, 1) interval, we observed a peak TLOD score of
13.75 at 37.04 cM, which is more similar to the results for
the high-LD SNP elimination methods. However, because
the high-LD SNP elimination methods all used the tradi-
tional (0, 0.5) interval, the comparison is not ideal. We
also note that maximization of LOD scores over the (0, 1)
interval resulted in general symmetry of the LOD function
about a recombination fraction of 0.5. This is most likely
due to a heavy reliance on two-generation pedigrees in the
GAW15 NARAC data resource with no phase information.
Any asymmetry in the chromosome 6 and 21 regions may
be due to inadequate modeling of parameters [21] or fail-
ure of the sampler to mix between phase states in the few
three or more generation families.
The three high-LD elimination methods all peaked at the
same position, but with different peak heights. We exam-
ined residual LD between all pairs of SNPs for each of the
LD elimination methods. Using a threshold for high LD of
D' > 0.7, the number of pairs exceeding the threshold was
less than 0.7% compared to the total number of pairwise
comparisons for each method across both chromosomes,
suggesting that the majority of high-LD SNPs pairs were
captured. However, we do note that for chromosome 6,
although the percentages were small, the number of pairs
of SNPs exceeding the threshold tended to follow the
Table 1: Data description across peak regions
Chromosome 6 Chromosome 21
Number of markers Median [interquartile] distance (Mb) 
between SNPs
Number of markers Median [interquartile] distance (Mb) 
between SNPs
Complete SNP set 242 0.313 [0.162, 0.583] 70 0.196 [0.031, 0.443]
PCA-Haplotype 201 0.391 [0.221, 0.712] 52 0.330 [0.160, 0.569]
PCA-Genotype 79 0.833 [0.505, 2.042] 35 0.445 [0.231, 0.781]
SNPLINK 202 0.406 [0.234, 0.688] 48 0.390 [0.190, 0.582]BMC Proceedings 2007, 1(Suppl 1):S160 http://www.biomedcentral.com/1753-6561/1/S1/S160
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Chromosome 6 linkage results using the complete SNP set Figure 1
Chromosome 6 linkage results using the complete SNP set.
Chromosome 21 linkage results using the complete SNP set Figure 2
Chromosome 21 linkage results using the complete SNP set.BMC Proceedings 2007, 1(Suppl 1):S160 http://www.biomedcentral.com/1753-6561/1/S1/S160
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same pattern as the peak TLOD results (i.e., LD threshold
pattern: PCA-genotype < PCA-haplotype < SNPLINK).
Thus, differences in peak height most likely are due to
residual LD in each of the methods. Although not investi-
gated here, it is also possible that the PCA-genotype
method, which is the most conservative, may have dimin-
ished power compared to the other two LD elimination
methods as more SNPs were eliminated. The PCA meth-
ods provided a logical approach to elimination of SNPs
that were not based on a contiguous LD structure or ran-
dom elimination of SNPs from a high-LD set as does
SNPLINK. Because an automated PCA package for remov-
ing high-LD SNPs is yet to be developed, we recommend
that PCA be used only for follow-up of regions with at
least suggestive linkage evidence.
Conclusion
Control for LD is an essential component of analyzing
high-density SNP linkage data, and inflated linkage peaks
may result if some method for controlling for LD is not
implemented. Because we observed differences in linkage
peak height and position across the four methods studied
here, further work is needed to explore these and other LD
control methods.
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